U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
The Parent Company was added by ICIJ.
The parent company information is based on 2017 public records.
데이터 추가 비고
Software, transmission and storage, patient data - Product Code NSX
원인
The bd max system software version 4.44a contains a software anomaly that has the potential to affect some open system reagent (osr) customers utilizing user defined protocol (udp) assays. customers utilizing only ivd assays are not affected.
this anomaly may cause the osr customer system to incorrectly switch the columns of the truth table on the users display. if the user tries to fix their display data, the display will appear correct however, the database may become incorrect, potentially resulting in incorrect results reporting.
bd is able to trace the issue to a limited number of instruments that have software version 4.44a installed. note that the problem only affects customers that are either creating a new udp with result logic or modifying the result logic of an existing udp.
조치
BD sent an Urgent Field Corrective Action Recall notification was initiated on July 29, 2015. The customer was initially contacted via a phone call and subsequently provided with a written communication. All US customers were contacted directly by phone and provided the written communication.
Global holds were placed on July 21, 2015 and July 24, 2015. For further questions, please call (410) 316-4000.
Worldwide Distribution - US Distribution to the states of : CA, CO, FL, IL, MN, MO, MT, NE, NJ, NY, OH, OR, PA, TX, TN, WA, WI., and to the countries of : Canada, Hong Kong, Taiwan, Turkey and Europe. Federal Government Agency sales/distribution centers or foreign countries VA Fort Harrison and VAMC Austin.
제품 설명
Software version 4.44A utilized on the BD MAX System